In this section, we have gathered all the key news related to the company – press releases, upcoming events, initiatives, and awards – as well as topics of interest in the world of Artificial Intelligence.
The continuous advancement in medicine and artificial intelligence is enriched by a series of open competitions designed to challenge data scientists, medical professionals, and researchers to develop new solutions for increasingly complex problems. KiTS 2023 (Kidney and Kidney Tumor Segmentation Challenge) marks the…
n recent years, synbrAIn has achieved major recognition and funding at both national and international levels, thanks to its strong work culture and commitment to delivering high-quality and innovative products. Through collaborations with our partners, we have been able to develop cutting-edge AI-powered…
In an exclusive video interview with Story Time, Roberto Pagani, CEO of synbrAIn, offered insight into the world of this promising technology company. With a strong focus on the strategic use of artificial intelligence (AI), synbrAIn is committed to developing solutions that enhance…
In recent years, synbrAIn has made significant strides in the field of Digital Healthcare, developing numerous AI and machine learning-driven solutions to support medical diagnostics. Within this framework, a strong collaboration has emerged with EMME ESSE, a company with over 40 years of…
After four years of continuous collaboration, synbrAIn has acquired one of its key business partners: SenticLab. Founded in April 2017 in Iași, Northeastern Romania, SenticLab quickly established itself as a research-focused company, strengthened by its strong ties to the academic and university environment.…
MIA-COV19D is an international competition organized by the University of Lincoln (UK), aimed at developing new solutions for identifying COVID-19-related diseases through the analysis of lung CT images. The competition was held as part of ICCV 2021, one of the world’s leading scientific…
As we announced a few weeks ago, the launch of MS humanAId by Emme Esse has seen synbrAIn's active involvement in developing a system that leverages artificial intelligence to support diagnostic image analysis. Specifically, the development of the AID CHEST XR PNEUMO module…
The non-profit organization Cancro Primo Aiuto has acquired the MS humanAId platform, developed by EMME ESSE, a synbrAIn partner, to donate it to ASST Brianza, enabling its deployment in additional hospitals across Lombardy. With MS humanAId, radiologists will have access to a range…
ImageCLEF is an international initiative organized by the CLEF initiative lab, aimed at fostering the development of new AI and machine learning-based solutions to address challenges in the healthcare and medical domains. This year’s edition focused on developing the best possible solution for…
Among the various collaborations initiated by synbrAIn, one stands out as particularly significant in the healthcare sector: its partnership with Emme Esse. Emme Esse is a company with over 40 years of experience in developing electronic solutions across various industries, including healthcare, specializing…
